EXPRESS SCRIPTS HLDG CO's ticker is ESRX and the CUSIP is 30219G108.
About EXPRESS SCRIPTS HLDG CO
Express Scripts Holding Company is a pharmacy benefit management company that provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy services, specialty pharmacy benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. The company operates in the United States and Canada.
Express Scripts Holding Company has been in the news recently due to its acquisition by Cigna Corporation. The acquisition was completed in December 2018, and the combined company is now one of the largest healthcare companies in the world.
The acquisition is expected to bring significant benefits to both companies. Express Scripts will benefit from Cigna's extensive network of healthcare providers, while Cigna will benefit from Express Scripts' expertise in pharmacy benefit management.
Express Scripts Holding Company has a strong track record of growth and profitability. In 2017, the company reported revenue of $100.1 billion and net income of $4.5 billion. The company's stock has also performed well, with a 52-week high of $101.73 and a 52-week low of $64.46.
Overall, Express Scripts Holding Company is a strong player in the healthcare industry, with a solid track record of growth and profitability. The company's acquisition by Cigna Corporation is expected to bring significant benefits to both companies, and investors should keep an eye on the combined company's performance in the coming years.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,395,000 | +23.0% | 94,595 | -4.4% | 2.26% | +10.9% |
| Q2 2018 | $7,638,000 | +3.8% | 98,929 | -7.2% | 2.04% | -3.1% |
| Q1 2018 | $7,360,000 | -13.5% | 106,549 | -6.5% | 2.11% | -14.5% |
| Q4 2017 | $8,509,000 | +137.2% | 114,005 | +102.9% | 2.46% | +104.7% |
| Q3 2017 | $3,587,000 | 0.0% | 56,191 | 0.0% | 1.20% | +2.4% |
| Q2 2017 | $3,587,000 | -6.3% | 56,191 | -3.3% | 1.18% | -15.5% |
| Q1 2017 | $3,828,000 | -5.9% | 58,086 | -1.8% | 1.39% | -9.3% |
| Q4 2016 | $4,070,000 | -5.1% | 59,161 | -2.7% | 1.53% | -10.7% |
| Q3 2016 | $4,289,000 | -6.0% | 60,812 | +1.0% | 1.72% | -7.4% |
| Q2 2016 | $4,565,000 | +11.0% | 60,227 | +0.6% | 1.86% | +5.3% |
| Q1 2016 | $4,111,000 | -19.5% | 59,855 | +2.5% | 1.76% | -20.9% |
| Q4 2015 | $5,104,000 | +9.2% | 58,390 | +1.2% | 2.23% | +5.3% |
| Q3 2015 | $4,673,000 | -8.7% | 57,720 | +0.3% | 2.12% | -5.3% |
| Q2 2015 | $5,118,000 | +4.0% | 57,540 | +1.5% | 2.23% | +1.4% |
| Q1 2015 | $4,920,000 | +1.2% | 56,700 | -1.2% | 2.20% | +1.1% |
| Q4 2014 | $4,860,000 | +22.3% | 57,400 | +2.0% | 2.18% | +18.9% |
| Q3 2014 | $3,973,000 | +5.1% | 56,250 | +3.1% | 1.83% | +4.9% |
| Q2 2014 | $3,782,000 | +9.4% | 54,550 | +18.5% | 1.75% | +0.3% |
| Q1 2014 | $3,458,000 | +9.4% | 46,045 | +2.3% | 1.74% | -0.2% |
| Q4 2013 | $3,161,000 | +38.9% | 45,000 | +22.2% | 1.74% | +9.7% |
| Q3 2013 | $2,276,000 | +4.8% | 36,825 | +4.7% | 1.59% | +0.3% |
| Q2 2013 | $2,172,000 | – | 35,175 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chieftain Capital Management, Inc. | 3,499,210 | $296,278,000 | 16.54% |
| GREEN VALLEY INVESTORS LLC | 9,050,000 | $766,265,000 | 16.13% |
| BloombergSen Inc. | 2,092,835 | $177,200,000 | 12.55% |
| Brave Warrior Advisors | 4,088,652 | $346,186,000 | 12.05% |
| St. James Investment Company, LLC | 1,119,811 | $94,814,000 | 10.33% |
| FPR PARTNERS LLC | 4,037,348 | $341,842,000 | 10.30% |
| Tesuji Partners | 1,800,000 | $152,406,000 | 9.78% |
| CORTLAND ASSOCIATES INC/MO | 545,932 | $46,224,000 | 9.48% |
| TIMUCUAN ASSET MANAGEMENT INC/FL | 933,529 | $79,042,000 | 8.53% |
| CAPITAL COUNSEL LLC/NY | 2,091,600 | $177,096,000 | 8.32% |